US6474369B2
(en)
|
1995-05-26 |
2002-11-05 |
Penjet Corporation |
Apparatus and method for delivering a lyophilized active with a needle-less injector
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
US6223786B1
(en)
|
1998-11-14 |
2001-05-01 |
Pen Jet Corporation |
Apparatus and method for mixing medication and filling an ampule of a needle-less injector
|
FR2739562B1
(fr)
*
|
1995-10-09 |
1998-04-24 |
Moreau Defarges Alain |
Dispositif d'injection par jet sans aiguille, comportant une cartouche surmoulee
|
US6080130A
(en)
*
|
1998-11-14 |
2000-06-27 |
Castellano; Thomas P. |
Gas power source for a needle-less injector
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
US6004287A
(en)
*
|
1997-09-23 |
1999-12-21 |
Loomis; Dale J |
Biolistic apparatus for delivering substances into cells and tissues
|
DE19820172A1
(de)
*
|
1997-09-30 |
2005-01-27 |
Wolfgang Wagner |
Einrichtung und einrichtungsbezogenes Verfahren zur Einbringung eines Diagnostikträgers oder einer Arznei unter die Haut eines Lebewesens
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
US6156008A
(en)
*
|
1998-05-04 |
2000-12-05 |
Castellano; Thomas P. |
Device for avoiding subdermal hematomas from an injection
|
EP1100566A4
(de)
*
|
1998-07-27 |
2002-03-20 |
Medi Ject Corp |
Lademechanismus für ein medizinisches injektionssystem
|
US6689093B2
(en)
|
1998-11-18 |
2004-02-10 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6783509B1
(en)
|
1998-11-18 |
2004-08-31 |
Bioject Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6406455B1
(en)
*
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
DE19859137C1
(de)
*
|
1998-12-21 |
2000-05-18 |
Ferton Holding Sa |
Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
AU4656000A
(en)
*
|
1999-04-22 |
2000-11-10 |
Gilbert Garitano |
Needleless permanent makeup and tattoo device
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
AU5595300A
(en)
*
|
1999-06-02 |
2000-12-18 |
Microheart, Inc. |
Devices and methods for delivering a drug
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
US20010027293A1
(en)
*
|
1999-06-29 |
2001-10-04 |
Ashok V. Joshi |
Storage stable fluid injection device and associated process
|
US6626871B1
(en)
|
1999-10-11 |
2003-09-30 |
Felton International, Inc. |
Method and apparatus for removing cap from medical device
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
FI115664B
(fi)
*
|
1999-10-20 |
2005-06-15 |
Uponor Innovation Ab |
Liitosyhde
|
US6673035B1
(en)
|
1999-10-22 |
2004-01-06 |
Antares Pharma, Inc. |
Medical injector and medicament loading system for use therewith
|
FR2800619B1
(fr)
*
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
Seringue sans aiguille avec un moyen de poussee temporairement retenu
|
US6254579B1
(en)
*
|
1999-11-08 |
2001-07-03 |
Allergan Sales, Inc. |
Multiple precision dose, preservative-free medication delivery system
|
DE19955201A1
(de)
*
|
1999-11-16 |
2001-05-31 |
Roesch Ag Medizintechnik |
Injektionseinrichtung
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
AU1927701A
(en)
*
|
1999-11-23 |
2001-06-04 |
Needleless Ventures, Inc. |
Injector assembly with driving means and locking means
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
WO2001051109A1
(en)
*
|
2000-01-07 |
2001-07-19 |
Biovalve Technologies, Inc. |
Injection device
|
US6210359B1
(en)
|
2000-01-21 |
2001-04-03 |
Jet Medica, L.L.C. |
Needleless syringe
|
FR2804869B1
(fr)
*
|
2000-02-11 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille pour l'injection d'un liquide contenu dans une ampoule pre-remplie
|
AU2001247721A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Antares Pharma, Inc. |
Single use disposable jet injector
|
FR2809626B1
(fr)
*
|
2000-05-30 |
2003-03-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille avec membrane d'isolation d'un ejecteur multiconduit
|
US6629958B1
(en)
|
2000-06-07 |
2003-10-07 |
Ronald P. Spinello |
Leak sealing needle
|
US6406456B1
(en)
|
2000-06-08 |
2002-06-18 |
Avant Drug Delivery Systems, Inc. |
Jet injector
|
DE10029325A1
(de)
*
|
2000-06-20 |
2002-01-03 |
Peter Lell |
Nadellose Injektionsvorrichtung mit pyrotechnischem Antrieb
|
FR2810554B1
(fr)
*
|
2000-06-22 |
2003-05-16 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un reservoir modulable
|
FR2812202B1
(fr)
*
|
2000-07-28 |
2002-09-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par mise en compression du reservoir contenant le principe actif liquide
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
CA2324045A1
(fr)
*
|
2000-10-20 |
2002-04-20 |
Universite De Sherbrooke |
Seringue sans aiguille pour l'injection sous-cutanee de poudres medicamenteuses
|
US8071740B2
(en)
*
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
EP1339442A4
(de)
*
|
2000-11-30 |
2006-12-27 |
Biovalve Technologies Inc |
Injektionssysteme
|
CA2438942A1
(en)
|
2001-02-23 |
2002-09-26 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
US6645170B2
(en)
|
2001-03-05 |
2003-11-11 |
Bioject Medical Technologies, Inc. |
Simplified disposable needle-free injection apparatus and method
|
US6471669B2
(en)
|
2001-03-05 |
2002-10-29 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
CA2440983A1
(en)
|
2001-03-14 |
2002-09-26 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
BR0116984A
(pt)
|
2001-04-13 |
2004-06-29 |
Penjet Corp |
Injetor sem agulha com pressurização a gás modular
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
WO2002087663A2
(en)
|
2001-04-27 |
2002-11-07 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
US6752781B2
(en)
*
|
2001-06-08 |
2004-06-22 |
Sergio Landau |
Durable hypodermic jet injector apparatus and method
|
US7544188B2
(en)
*
|
2001-07-19 |
2009-06-09 |
Intelliject, Inc. |
Medical injector
|
JP4173446B2
(ja)
|
2001-10-19 |
2008-10-29 |
ヴァスキュラー バイオジェニックス リミテッド |
血管形成の標的化されたダウンレギュレーションおよび抗ガン治療のためのポリヌクレオチド構築物および薬学的組成物および方法
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
US6607510B2
(en)
|
2001-11-09 |
2003-08-19 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
DE10155344A1
(de)
*
|
2001-11-10 |
2003-05-28 |
Schott Glas |
Behältnissystem zur nadellosen Injektion von medizinisch wirksamen Substanzen
|
CA2467719C
(en)
|
2001-11-14 |
2015-03-17 |
Jill Giles-Komar |
Anti-il-6 antibodies, compositions, methods and uses
|
EP1470161A1
(de)
*
|
2002-01-18 |
2004-10-27 |
Inovio AS |
Bispezifische antikörper-dna-konstrukte für die intramuskuläre verabreichung
|
EP1476210B1
(de)
|
2002-02-11 |
2008-09-24 |
Antares Pharma, Inc. |
Intradermales injektionsgerät
|
WO2003074102A2
(en)
*
|
2002-03-04 |
2003-09-12 |
Nano Pass Technologies Ltd. |
Devices and methods for transporting fluid across a biological barrier
|
GB0206560D0
(en)
*
|
2002-03-20 |
2002-05-01 |
Glaxo Group Ltd |
Novel device
|
US20030196928A1
(en)
*
|
2002-04-19 |
2003-10-23 |
Parsons J. Stuart |
Multi-component ampule
|
WO2003103751A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Akzo Nobel N.V. |
Needle-less injector
|
WO2004002417A2
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
AU2003243875B2
(en)
*
|
2002-07-11 |
2006-07-06 |
Tecpharma Licensing Ag |
Needle-free injection device
|
US7081109B2
(en)
*
|
2002-08-22 |
2006-07-25 |
Baxa Corporation |
Sterile docking apparatus and method
|
MXPA05002072A
(es)
|
2002-08-26 |
2005-06-08 |
Penjet Corp |
Aparato para inyeccion sin aguja de fluido desgasificado.
|
FR2852517B1
(fr)
*
|
2003-03-21 |
2005-11-11 |
|
Dispositif d'injection sans aiguille a cartouche pyrotechnique et procede d'assemblage d'un tel dispositif
|
US8012136B2
(en)
*
|
2003-05-20 |
2011-09-06 |
Optimyst Systems, Inc. |
Ophthalmic fluid delivery device and method of operation
|
CA2526362C
(en)
*
|
2003-05-20 |
2012-10-09 |
James F. Collins |
Ophthalmic drug delivery system
|
AU2004272972A1
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
WO2004112871A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Allergan, Inc. |
Needless injectors
|
US20070293447A1
(en)
*
|
2003-08-29 |
2007-12-20 |
Yasuo Kunugiza |
Gene Therapy for Skin Disorders Using Needleless Syringes
|
WO2005034949A1
(en)
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
IL157984A
(en)
|
2003-09-17 |
2015-02-26 |
Dali Medical Devices Ltd |
Automatic needle
|
IL157981A
(en)
|
2003-09-17 |
2014-01-30 |
Elcam Medical Agricultural Cooperative Ass Ltd |
Auto injector
|
PL2332968T3
(pl)
|
2003-11-05 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Stabilizowane alfa-helikalne peptydy i ich zastosowania
|
EP1699524A4
(de)
*
|
2003-11-18 |
2009-07-15 |
Nanopass Technologies Ltd |
Verbessertes penetrationssystem und verfahren zum schieben von mikronadeln
|
CA2546468C
(en)
*
|
2003-12-05 |
2015-05-26 |
Aradigm Corporation |
A device for readying a needle free injector for delivery
|
EP1722842A1
(de)
*
|
2004-01-26 |
2006-11-22 |
The Medical House Plc |
Nadelfreie injektionsvorrichtung
|
US7717879B2
(en)
*
|
2004-02-03 |
2010-05-18 |
Smjm Inject Gmbh |
Anesthetic syringe
|
IL160891A0
(en)
|
2004-03-16 |
2004-08-31 |
|
Auto-mix needle
|
EP1750754A4
(de)
*
|
2004-03-31 |
2010-09-22 |
Centocor Ortho Biotech Inc |
Menschliche glp-1-mimetikörper; zusammensetzungen; verfahren und anwendungen
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
EP1773439A4
(de)
*
|
2004-07-14 |
2010-01-20 |
By Pass Inc |
Materialablagesystem
|
US7910787B2
(en)
*
|
2004-07-29 |
2011-03-22 |
Gas Technologies Llc |
Method and system for methanol production
|
US9180426B2
(en)
|
2004-07-29 |
2015-11-10 |
Gas Technologies, Llc |
Scrubber for methanol production system
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
CA2580103C
(en)
|
2004-09-22 |
2021-11-16 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US7947017B2
(en)
|
2004-11-22 |
2011-05-24 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US10737028B2
(en)
|
2004-11-22 |
2020-08-11 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
AU2004325202B2
(en)
|
2004-11-22 |
2009-02-19 |
Kaleo, Inc. |
Devices, systems, and methods for medicament delivery
|
US11590286B2
(en)
|
2004-11-22 |
2023-02-28 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
US7648483B2
(en)
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US7648482B2
(en)
*
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems, and methods for medicament delivery
|
EP2532378B1
(de)
*
|
2004-12-01 |
2016-04-27 |
AcuShot, Inc. |
Nadelloser Injektor
|
JP5216328B2
(ja)
|
2005-01-24 |
2013-06-19 |
アンタレス ファーマ インコーポレイテッド |
あらかじめ充填された針補助シリンジジェット式注射器
|
PL2058020T3
(pl)
|
2005-02-01 |
2013-03-29 |
Kaleo Inc |
Urządzenie do podawania leków
|
US7731686B2
(en)
|
2005-02-01 |
2010-06-08 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US8231573B2
(en)
|
2005-02-01 |
2012-07-31 |
Intelliject, Inc. |
Medicament delivery device having an electronic circuit system
|
US9022980B2
(en)
|
2005-02-01 |
2015-05-05 |
Kaleo, Inc. |
Medical injector simulation device
|
US8206360B2
(en)
|
2005-02-01 |
2012-06-26 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US8361026B2
(en)
|
2005-02-01 |
2013-01-29 |
Intelliject, Inc. |
Apparatus and methods for self-administration of vaccines and other medicaments
|
EP1861122A1
(de)
|
2005-03-23 |
2007-12-05 |
GlaxoSmithKline Biologicals S.A. |
Zusammensetzung
|
MX2007012226A
(es)
|
2005-04-04 |
2007-12-10 |
Univ Florida |
Analogos de polieter de desferritiocina.
|
PA8672101A1
(es)
|
2005-04-29 |
2006-12-07 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, métodos y usos
|
US7611505B2
(en)
*
|
2005-05-10 |
2009-11-03 |
Baxa Corporation |
Sterile docking apparatus and method
|
EP1896073B1
(de)
|
2005-06-30 |
2013-03-06 |
Janssen Biotech, Inc. |
Anti-il-23-antikörper, zusammensetzungen, verfahren und verwendung
|
KR101446025B1
(ko)
|
2005-08-03 |
2014-10-01 |
아이바이오, 인크. |
면역글로불린의 생산을 위한 조성물 및 방법
|
US8998881B2
(en)
*
|
2005-08-10 |
2015-04-07 |
Alza Corporation |
Method for delivering drugs to tissue under microjet propulsion
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
ES2707499T3
(es)
|
2005-12-22 |
2019-04-03 |
Glaxosmithkline Biologicals Sa |
Vacuna de conjugado de polisacárido neumocócico
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
HUE049832T2
(hu)
|
2005-12-29 |
2020-10-28 |
Janssen Biotech Inc |
Humán anti-IL-23 ellenanyagok, készítmények, eljárás és alkalmazások
|
CA2642054C
(en)
|
2006-02-13 |
2017-11-21 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
EP1998802A2
(de)
|
2006-03-30 |
2008-12-10 |
GlaxoSmithKline Biologicals S.A. |
Immunogene zusammensetzung
|
CA2648035A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Centocor, Inc. |
Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US20070254381A1
(en)
*
|
2006-04-27 |
2007-11-01 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Monitoring and/or treating syringe mechanism
|
US8251947B2
(en)
|
2006-05-03 |
2012-08-28 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
US20070260174A1
(en)
*
|
2006-05-05 |
2007-11-08 |
Searete Llc |
Detecting a failure to maintain a regimen
|
CN101573141B
(zh)
|
2006-05-15 |
2016-05-04 |
麻省理工学院 |
用于功能性颗粒的聚合物
|
US9150626B2
(en)
|
2006-06-02 |
2015-10-06 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
EP2422810B1
(de)
|
2006-07-17 |
2014-10-22 |
GlaxoSmithKline Biologicals s.a. |
Influenzaimpfstoff
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
DE202006018609U1
(de)
*
|
2006-08-29 |
2007-05-16 |
Euro-Celtique S.A. |
Verwendung von Opioidformulierungen in nadellosen Vorrichtungen zur Medikamentenverabreichung
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
PL2086582T3
(pl)
|
2006-10-12 |
2013-04-30 |
Glaxosmithkline Biologicals Sa |
Kompozycja zawierająca adiuwant w postaci emulsji typu olej w wodzie
|
CN101522218B
(zh)
|
2006-10-12 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
包含水包油乳液佐剂的疫苗
|
DE202006017522U1
(de)
*
|
2006-11-15 |
2007-01-18 |
Perma-Tec Gmbh & Co. Kg |
Schmierstoffspender
|
CA2671447A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
US20080140001A1
(en)
*
|
2006-12-12 |
2008-06-12 |
By-Pass Inc. |
Fluid Delivery Apparatus And Methods
|
TW200843794A
(en)
*
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
CN105622463B
(zh)
|
2006-12-26 |
2019-02-22 |
兰休斯医疗成像公司 |
用于使心脏神经支配成像的配体
|
US20080171968A1
(en)
*
|
2007-01-15 |
2008-07-17 |
Bioject, Inc. |
Methods of administering injectables to a joint with a needle-free injection system
|
EP2125075A2
(de)
|
2007-01-22 |
2009-12-02 |
Intelliject, Inc. |
Medizinischer injektor mit konformitätsverfolgung und -überwachung
|
PT2118123E
(pt)
|
2007-01-31 |
2016-02-10 |
Harvard College |
Péptidos de p53 estabilizados e suas utilizações
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008103997A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
WO2008115433A1
(en)
|
2007-03-15 |
2008-09-25 |
University Of Florida |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
EP2508531B1
(de)
|
2007-03-28 |
2016-10-19 |
President and Fellows of Harvard College |
Geheftete Polypeptide
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
US8778348B2
(en)
|
2007-04-28 |
2014-07-15 |
Ibio Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
RS54349B1
(en)
|
2007-06-26 |
2016-02-29 |
Glaxosmithkline Biologicals S.A. |
VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
|
WO2009009759A2
(en)
|
2007-07-11 |
2009-01-15 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
CN105770878A
(zh)
|
2007-10-12 |
2016-07-20 |
麻省理工学院 |
疫苗纳米技术
|
PL2214699T3
(pl)
|
2007-11-02 |
2017-05-31 |
Grifols Therapeutics Inc. |
Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny
|
US9533098B2
(en)
|
2007-11-19 |
2017-01-03 |
Painless Tech Gmbh |
Injection device for the needle-free injection of a medium
|
CA2711330A1
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US20090212133A1
(en)
*
|
2008-01-25 |
2009-08-27 |
Collins Jr James F |
Ophthalmic fluid delivery device and method of operation
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
WO2009126691A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
WO2009127676A1
(en)
|
2008-04-16 |
2009-10-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
USD994111S1
(en)
|
2008-05-12 |
2023-08-01 |
Kaleo, Inc. |
Medicament delivery device cover
|
US8021344B2
(en)
|
2008-07-28 |
2011-09-20 |
Intelliject, Inc. |
Medicament delivery device configured to produce an audible output
|
US20090291986A1
(en)
|
2008-05-22 |
2009-11-26 |
Apostolos Pappas |
Composition and method of treating facial skin defect
|
CN105147608B
(zh)
|
2008-06-26 |
2019-12-10 |
安特里奥公司 |
真皮递送
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
US20110144306A1
(en)
|
2008-07-23 |
2011-06-16 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
JP5611208B2
(ja)
|
2008-08-05 |
2014-10-22 |
アンタレス・ファーマ・インコーポレーテッド |
多数回服用量の注射装置
|
CA2733642A1
(en)
|
2008-08-14 |
2010-02-18 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
US8650937B2
(en)
|
2008-09-19 |
2014-02-18 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
US9206223B2
(en)
|
2008-09-22 |
2015-12-08 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
US8663196B2
(en)
*
|
2008-09-23 |
2014-03-04 |
Kassab Kughn Endovascular Devices Llc |
Endovascular sheath with gradable stiffness device and method
|
DE102008048595A1
(de)
|
2008-09-23 |
2010-04-01 |
Lts Lohmann Therapie-Systeme Ag |
Einweginjektor mit hoher Injektionssicherheit
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
BRPI0919881B1
(pt)
|
2008-10-31 |
2021-09-08 |
Centocor Ortho Biotech Inc |
Proteína de arcabouço e seu método de geração, biblioteca e seu método de construção, molécula de ácido nucleico, vetor de ácido nucleico, célula hospedeira, composição, dispositivo médico e artigo de fabricação
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
EP2376619A4
(de)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
Verfahren zur flusssteuerung bei stoffwechselwegen
|
CN102256615A
(zh)
|
2009-01-14 |
2011-11-23 |
爱勒让治疗公司 |
拟肽大环化合物
|
EP2396011B1
(de)
|
2009-02-12 |
2016-04-13 |
Janssen Biotech, Inc. |
Auf fibronectin-typ-iii-domain basierende gerüstzusammensetzungen, verfahren und anwendung
|
WO2010108116A1
(en)
|
2009-03-20 |
2010-09-23 |
Antares Pharma, Inc. |
Hazardous agent injection system
|
IL197761A0
(en)
*
|
2009-03-23 |
2009-12-24 |
Moshe Zalsman |
Capsule for mixing together two flowable materials, and kits including such capsules, particularly useful in dentistry
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
WO2010141074A2
(en)
|
2009-06-01 |
2010-12-09 |
President And Fellows Of Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
EP3284494A1
(de)
|
2009-07-30 |
2018-02-21 |
Tandem Diabetes Care, Inc. |
Tragbares infusionspumpensystem
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
EP2298390A1
(de)
*
|
2009-08-28 |
2011-03-23 |
Sanofi-Aventis Deutschland GmbH |
Medizinische Abgabevorrichtung, Gehäusekappe für eine medizinische Abgabevorrichtung und Antriebsmechanismus für eine medizinische Abgabevorrichtung
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US20140200511A1
(en)
*
|
2009-10-30 |
2014-07-17 |
Searete Llc |
Systems, devices, and methods for making or administering frozen particles
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011094445A1
(en)
|
2010-01-27 |
2011-08-04 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
KR101888026B1
(ko)
|
2010-02-03 |
2018-08-13 |
인피니티 파마슈티컬스, 인코포레이티드 |
지방산 아미드 하이드롤라제 저해제
|
WO2011098518A2
(en)
*
|
2010-02-11 |
2011-08-18 |
Ablynx Nv |
Delivery of immunoglobulin variable domains and constructs thereof
|
CN102844023B
(zh)
|
2010-03-08 |
2016-01-20 |
索隆-基特林癌症研究协会 |
Cdc7激酶抑制剂以及其用途
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP2566853B1
(de)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolone als fettsäuresynthasehemmer
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
DK2566953T3
(en)
|
2010-05-07 |
2019-04-15 |
Greenlight Biosciences Inc |
METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
|
RU2019142507A
(ru)
|
2010-05-11 |
2020-08-24 |
Лантеус Медикал Имэджинг, Инк. |
Композиции, способы и системы для синтеза и применение визуализирующих средств
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
US9193989B2
(en)
|
2010-06-18 |
2015-11-24 |
Taiho Pharmaceutical Co., Ltd. |
PRPK-TPRKB modulators and uses thereof
|
AU2011268110B2
(en)
|
2010-06-19 |
2016-05-19 |
Memorial Sloan-Kettering Cancer Center |
Anti-GD2 antibodies
|
US10154923B2
(en)
|
2010-07-15 |
2018-12-18 |
Eyenovia, Inc. |
Drop generating device
|
ES2787254T3
(es)
|
2010-07-15 |
2020-10-15 |
Eyenovia Inc |
Suministro de fármacos oftálmicos
|
JP2013531548A
(ja)
|
2010-07-15 |
2013-08-08 |
コリンシアン オフサルミック,インコーポレイティド |
遠隔治療及び遠隔モニタリングを実施する方法及びシステム
|
JP5964826B2
(ja)
|
2010-07-15 |
2016-08-03 |
アイノビア,インコーポレイティド |
滴生成デバイス
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CA2807685C
(en)
|
2010-08-13 |
2020-10-06 |
Aileron Therapeutics, Inc. |
P53 derived peptidomimetic macrocycle
|
CA2809284C
(en)
|
2010-08-31 |
2021-02-23 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
ES2862955T3
(es)
|
2010-10-01 |
2021-10-08 |
Modernatx Inc |
Acidos nucleicos manipulados y métodos de uso de los mismos
|
RU2663718C2
(ru)
|
2010-10-04 |
2018-08-08 |
Массачусетс Инститьют Оф Текнолоджи |
Полипептиды гемагглютининов, а также связанные с ними реагенты и способы
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
GB201021716D0
(en)
*
|
2010-12-22 |
2011-02-02 |
Owen Mumford Ltd |
Autoinjectors
|
AU2012205735B8
(en)
*
|
2011-01-10 |
2014-09-18 |
Zogenix, Inc. |
Needle free injectors
|
DK2663309T3
(en)
|
2011-01-10 |
2017-06-19 |
Infinity Pharmaceuticals Inc |
METHODS FOR PRODUCING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
|
WO2012099942A2
(en)
|
2011-01-19 |
2012-07-26 |
Terakine Therapeutics, Inc. |
Methods and compositions for treating metabolic syndrome
|
JP2014503586A
(ja)
|
2011-01-24 |
2014-02-13 |
アンテリオス, インコーポレイテッド |
油組成物
|
BR112013018920A2
(pt)
|
2011-01-24 |
2017-11-28 |
Anterios Inc |
composições de nanopartículas, formulações destas e seus usos
|
CN103747782A
(zh)
|
2011-01-24 |
2014-04-23 |
安特里奥公司 |
纳米颗粒组合物
|
US9173999B2
(en)
|
2011-01-26 |
2015-11-03 |
Kaleo, Inc. |
Devices and methods for delivering medicaments from a multi-chamber container
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
KR20140010126A
(ko)
|
2011-03-03 |
2014-01-23 |
터서스 파마수티칼 엘엘씨 |
C16:1n7-팔미톨리에이트를 포함하는 조성물들 및 방법들
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
UY34073A
(es)
|
2011-05-17 |
2013-01-03 |
Glaxosmithkline Biolog Sa |
Vacuna mejorada de streptococcus pneumoniae y métodos de preparación.
|
FR2976568B1
(fr)
*
|
2011-06-14 |
2014-09-05 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
US8672883B2
(en)
|
2011-07-11 |
2014-03-18 |
C. Garyen Denning |
Fluid delivery device and methods
|
US9220660B2
(en)
|
2011-07-15 |
2015-12-29 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
US8496619B2
(en)
|
2011-07-15 |
2013-07-30 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
AU2012284088B2
(en)
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
RS58438B1
(sr)
|
2011-07-22 |
2019-04-30 |
Massachusetts Inst Technology |
Aktivatori klase i histonskih deacetilaza (hdacs) i njihova primena
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
DK2753605T3
(da)
|
2011-09-09 |
2019-06-17 |
Lantheus Medical Imaging Inc |
Sammensætninger, fremgangsmåder, og systemer til syntesen og anvendelsen af billeddannelsesmidler
|
JP2014526250A
(ja)
|
2011-09-09 |
2014-10-06 |
グリーンライト バイオサイエンシーズ インコーポレーテッド |
カルバペネムの無細胞調製
|
EP3384938A1
(de)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Manipulierte nukleinsäuren und verfahren zur verwendung davon
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
WO2013052523A1
(en)
|
2011-10-03 |
2013-04-11 |
modeRNA Therapeutics |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
TWI643868B
(zh)
|
2011-10-18 |
2018-12-11 |
艾利倫治療公司 |
擬肽巨環化合物
|
EP2822935B1
(de)
|
2011-11-17 |
2019-05-15 |
Dana-Farber Cancer Institute, Inc. |
Inhibitoren der c-jun-n-terminal-kinase (jnk)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP2790620A1
(de)
|
2011-12-12 |
2014-10-22 |
Corinthian Ophthalmic, Inc. |
Polymerausstossmechanismus mit hohem modulus, ausstossvorrichtung und verwendungsverfahren dafür
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
MX362492B
(es)
|
2012-02-15 |
2019-01-21 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos.
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
KR20150011346A
(ko)
|
2012-04-06 |
2015-01-30 |
안타레스 팔마, 인코퍼레이티드 |
테스토스테론 조성물의 바늘-보조식 젯 주입 투여 장치 및 방법
|
EP2834254A2
(de)
|
2012-04-06 |
2015-02-11 |
President and Fellows of Harvard College |
Moenomycin-analoga, syntheseverfahren und verwendung
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
EP2850090B1
(de)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatische verfahren zur synthetisierung von moenomycin-analoga
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US9364610B2
(en)
|
2012-05-07 |
2016-06-14 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
BR112014027991A2
(pt)
|
2012-05-10 |
2017-07-18 |
Massachusetts Inst Technology |
agentes para neutralização de influenza
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US9522235B2
(en)
|
2012-05-22 |
2016-12-20 |
Kaleo, Inc. |
Devices and methods for delivering medicaments from a multi-chamber container
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
WO2014024026A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014042930A1
(en)
*
|
2012-09-17 |
2014-03-20 |
Hns International, Inc. |
Needleless hypodermic injector and related method
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
ES2719776T3
(es)
|
2012-10-12 |
2019-07-16 |
Broad Inst Inc |
Inhibidores de GSK3 y métodos de uso de los mismos
|
EP2909194A1
(de)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Hemmer der cyclinabhängigen kinase 7 (cdk7)
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US20140114248A1
(en)
*
|
2012-10-24 |
2014-04-24 |
Nuance Designs, LLC |
Power pack for an autoinjector
|
DK2914296T4
(da)
|
2012-11-01 |
2022-01-03 |
Infinity Pharmaceuticals Inc |
Behandling af cancere under anvendelse af PI3-kinase-isoform-modulatorer
|
EP2914256B1
(de)
|
2012-11-01 |
2019-07-31 |
Aileron Therapeutics, Inc. |
Disubstituierte aminosäuren und verfahren zur herstellung und verwendung davon
|
EP2917203B1
(de)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur identifizierung von myc inhibitoren
|
KR101651448B1
(ko)
|
2012-11-21 |
2016-08-26 |
토포카인 쎄라퓨틱스, 인코포레이티드 |
체지방을 국소적으로 증가시키는 방법 및 조성물
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
WO2014100695A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
US9745291B2
(en)
|
2012-12-21 |
2017-08-29 |
Epizyme, Inc. |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
MX2015008052A
(es)
|
2012-12-21 |
2016-08-18 |
Epizyme Inc |
Inhibidores de prmt5 y sus usos.
|
JP2016505001A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
CA2896708A1
(en)
|
2012-12-27 |
2014-07-03 |
Kaleo, Inc. |
Devices, systems and methods for locating and interacting with medicament delivery systems
|
EP2946014A2
(de)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor-polynukleotide zur veränderung zellulärer phänotypen
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
EP4349383A2
(de)
|
2013-02-11 |
2024-04-10 |
Antares Pharma, Inc. |
Nadelunterstützte strahlinjektionsvorrichtung mit reduzierter auslöserkraft
|
EP2968792B1
(de)
|
2013-03-11 |
2019-05-15 |
Antares Pharma, Inc. |
Dosierungsinjektor mit einem zahnradsystem
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
EP2970194A1
(de)
|
2013-03-15 |
2016-01-20 |
Infinity Pharmaceuticals, Inc. |
Salze und feste formen von isochinolinonen und zusammensetzung damit sowie verfahren zur verwendung davon
|
KR102207859B1
(ko)
|
2013-03-15 |
2021-01-27 |
메모리얼 슬로안 케터링 캔서 센터 |
고 친화도 항-gd2 항체
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
EP2988597B1
(de)
|
2013-04-04 |
2022-06-08 |
President and Fellows of Harvard College |
Makrolide sowie verfahren zu deren herstellung und verwendung
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(de)
|
2013-05-10 |
2018-06-16 |
|
|
WO2014186504A1
(en)
|
2013-05-15 |
2014-11-20 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
DK3003309T3
(da)
|
2013-05-30 |
2020-12-14 |
Infinity Pharmaceuticals Inc |
Behandling af cancer med PI3-kinase-isoform modulatorer
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
US9212145B2
(en)
|
2013-06-11 |
2015-12-15 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
AU2014278005B2
(en)
|
2013-06-14 |
2018-11-22 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
EP3024327B1
(de)
|
2013-07-25 |
2019-09-04 |
Dana-Farber Cancer Institute, Inc. |
Hemmer von transkriptionsfaktoren und verwendungen davon
|
EP3030260A1
(de)
|
2013-08-05 |
2016-06-15 |
GlaxoSmithKline Biologicals S.A. |
Immunogene kombinationszusammensetzungen
|
WO2015021058A2
(en)
|
2013-08-05 |
2015-02-12 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
CA2923579C
(en)
|
2013-09-06 |
2023-09-05 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
NZ718430A
(en)
|
2013-10-04 |
2021-12-24 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
JP6491202B2
(ja)
|
2013-10-18 |
2019-03-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US11446309B2
(en)
|
2013-11-08 |
2022-09-20 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
|
US20160243544A1
(en)
*
|
2013-11-14 |
2016-08-25 |
Abon Biopharm (Hangzhou) Co., Ltd. |
A device and method for using the device
|
CN106103452B
(zh)
|
2013-12-24 |
2019-05-21 |
哈佛学院院长等 |
皮质抑素类似物及其合成和用途
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
TW201620939A
(zh)
|
2014-01-16 |
2016-06-16 |
中央研究院 |
治療及檢測癌症之組合物及方法
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
JP2017506666A
(ja)
|
2014-02-28 |
2017-03-09 |
テンシャ セラピューティクス,インコーポレイテッド |
高インスリン血症に関連した症状の処置
|
WO2015134920A1
(en)
|
2014-03-07 |
2015-09-11 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
|
JP6296840B2
(ja)
*
|
2014-03-11 |
2018-03-20 |
テルモ株式会社 |
液体投与具
|
JP6262030B2
(ja)
*
|
2014-03-11 |
2018-01-17 |
テルモ株式会社 |
液体投与具
|
EA201691872A1
(ru)
|
2014-03-19 |
2017-04-28 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
CN106456735B
(zh)
|
2014-03-28 |
2021-06-29 |
华盛顿大学商业中心 |
乳腺癌和卵巢癌疫苗
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
WO2015179635A2
(en)
|
2014-05-21 |
2015-11-26 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
JP2017518989A
(ja)
|
2014-05-27 |
2017-07-13 |
アカデミア シニカAcademia Sinica |
抗cd20糖操作抗体群およびその使用
|
WO2015184008A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Fucosidase from bacteroides and methods using the same
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
WO2015187802A1
(en)
|
2014-06-03 |
2015-12-10 |
Amgen Inc. |
Devices and methods for assisting a user of a drug delivery device
|
JP6664338B2
(ja)
|
2014-06-13 |
2020-03-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組合せ物
|
CN106559991B
(zh)
|
2014-06-19 |
2019-09-20 |
阿里亚德医药股份有限公司 |
用于激酶抑制的杂芳基化合物
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
EP3164379A1
(de)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Lipidoide aus polyaminfettsäure und verwendungen davon
|
US10182906B2
(en)
*
|
2014-07-15 |
2019-01-22 |
Alcon Pharmaceuticals, Ltd. |
Intraocular lens inserter with temperature compensation
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
WO2016011386A1
(en)
|
2014-07-18 |
2016-01-21 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
CN104162207A
(zh)
*
|
2014-08-27 |
2014-11-26 |
苏州承乐电子科技有限公司 |
一种持续型无针注射器
|
CA2960712A1
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Human inkt cell activation using glycolipids
|
CN107106642B
(zh)
|
2014-09-24 |
2021-02-26 |
艾瑞朗医疗公司 |
拟肽大环化合物及其制剂
|
SG10201902594QA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
AU2015335950B2
(en)
|
2014-10-21 |
2018-01-25 |
Takeda Pharmaceutical Company Limited |
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}pyrimidine-2,4-diamine
|
CA2965330A1
(en)
|
2014-10-27 |
2016-05-06 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
JP2017533238A
(ja)
|
2014-10-28 |
2017-11-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗原特異的寛容のための組成物及び方法
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
US10174022B2
(en)
|
2014-12-10 |
2019-01-08 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
|
ES2785311T3
(es)
|
2014-12-19 |
2020-10-06 |
Amgen Inc |
Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
US10314815B2
(en)
|
2014-12-23 |
2019-06-11 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin B
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
新規なグリカンコンジュゲートおよびその使用方法
|
KR102618312B1
(ko)
|
2015-03-17 |
2023-12-28 |
메모리얼 슬로안 케터링 캔서 센터 |
항muc16 항체 및 그의 용도
|
AU2016235424A1
(en)
|
2015-03-20 |
2017-10-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
CA2980004C
(en)
|
2015-03-24 |
2023-10-10 |
Kaleo, Inc. |
Devices and methods for delivering a lyophilized medicament
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
EP3277808A4
(de)
|
2015-03-30 |
2019-05-22 |
Greenlight Biosciences, Inc. |
Zellfreie herstellung von ribonukleinsäure
|
EP3288557A4
(de)
|
2015-04-27 |
2018-11-07 |
University of Florida Research Foundation, Inc. |
Metabolisch programmierte metallchelatoren und verwendungen davon
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
HRP20230494T1
(hr)
|
2015-06-19 |
2023-08-04 |
Massachusetts Institute Of Technology |
Alkenil supstituirani 2,5-piperazindioni i njihova upotreba u pripravcima za isporuku sredstva subjektu ili stanici
|
CA2990950A1
(en)
|
2015-06-30 |
2017-01-05 |
Kaleo, Inc. |
Auto-injectors for administration of a medicament within a prefilled syringe
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP3347372A4
(de)
|
2015-09-10 |
2019-09-04 |
Aileron Therapeutics, Inc. |
Peptidomimetische makrocyclen als modulatoren von mcl-1
|
DK3350333T3
(da)
|
2015-09-17 |
2022-01-31 |
Modernatx Inc |
Polynukleotider, der indeholder en stabiliserende haleregion
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
EP3355882A1
(de)
|
2015-10-01 |
2018-08-08 |
Kythera Biopharmaceuticals, Inc. |
Zusammensetzungen mit einem statin zur verwendung in verfahren zur adipolyse
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
DK3394030T3
(da)
|
2015-12-22 |
2022-03-28 |
Modernatx Inc |
Forbindelser og sammensætninger til intracellulær afgivelse af midler
|
CN109195996A
(zh)
|
2016-03-08 |
2019-01-11 |
中央研究院 |
N-聚醣及其阵列的模组化合成方法
|
US10918808B2
(en)
*
|
2016-03-09 |
2021-02-16 |
Portal Instruments, Inc. |
Angled injection nozzle
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
CN109071653A
(zh)
|
2016-03-29 |
2018-12-21 |
詹森生物科技公司 |
用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
|
US10954541B2
(en)
|
2016-04-06 |
2021-03-23 |
Greenlight Biosciences, Inc. |
Cell-free production of ribonucleic acid
|
WO2017196504A1
(en)
|
2016-05-10 |
2017-11-16 |
Sage Burton H Jr |
Spring-driven drug delivery device
|
TW201803615A
(zh)
*
|
2016-05-31 |
2018-02-01 |
賽諾菲阿凡提斯德意志有限公司 |
藥物輸送裝置的按鈕及組裝藥物輸送裝置的按鈕之方法
|
TWI729141B
(zh)
*
|
2016-05-31 |
2021-06-01 |
德商賽諾菲阿凡提斯德意志有限公司 |
藥物輸送裝置之蓋組合件及其組裝方法
|
CN115746107A
(zh)
|
2016-06-03 |
2023-03-07 |
圣诺菲·帕斯图尔公司 |
经改造的流感血凝素多肽的修饰
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP2019525901A
(ja)
|
2016-06-14 |
2019-09-12 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
脂質ナノ粒子の安定化製剤
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
RU2019104075A
(ru)
|
2016-07-15 |
2020-08-17 |
Посейда Терапьютикс, Инк. |
Химерные рецепторы антигенов (car), специфические для muc1, и способы их применения
|
US20190177421A1
(en)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors and methods for use
|
MX2019001341A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de polisacarido neumococico multivalente-proteina.
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
JP2020500152A
(ja)
|
2016-09-30 |
2020-01-09 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する安全かつ有効な方法
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
MX2019005661A
(es)
|
2016-11-16 |
2019-10-07 |
Janssen Biotech Inc |
Método para tratar la psoriasis con el anticuerpo específico anti-il23.
|
CN107050580B
(zh)
*
|
2016-11-28 |
2019-12-31 |
大连医科大学附属第二医院 |
带增压功能的自动复位无针注射器
|
CN106668992B
(zh)
*
|
2016-11-28 |
2019-07-12 |
合肥讯创信息科技有限公司 |
增压无针注射装置
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
WO2018119218A1
(en)
|
2016-12-23 |
2018-06-28 |
Kaleo, Inc. |
Medicament delivery device and methods for delivering drugs to infants and children
|
WO2018136413A2
(en)
|
2017-01-17 |
2018-07-26 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and event detection
|
EP3574012A1
(de)
|
2017-01-27 |
2019-12-04 |
Memorial Sloan Kettering Cancer Center |
Bispezifische her2- und cd3-bindende moleküle
|
MX2019008989A
(es)
|
2017-01-30 |
2019-10-09 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la artritis psoriasica activa.
|
GB2559553B
(en)
|
2017-02-06 |
2021-10-13 |
Consort Medical Plc |
A medicament delivery device
|
CN110418652A
(zh)
|
2017-02-07 |
2019-11-05 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
KR102643190B1
(ko)
|
2017-06-10 |
2024-03-04 |
아이노비아 인코포레이티드 |
유체를 취급하기 위한, 그리고 눈에 유체를 전달하기 위한 디바이스들
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
CN107252512B
(zh)
*
|
2017-06-16 |
2018-03-13 |
南阳市中心医院 |
一种气动无针注射器
|
EP3641828B1
(de)
|
2017-06-23 |
2023-11-22 |
Affinivax, Inc. |
Immunogene zusammensetzungen
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019040399A1
(en)
|
2017-08-22 |
2019-02-28 |
Shire-Nps Pharmaceuticals, Inc. |
GLP-2 FUSION POLYPEPTIDES AND USES THEREOF FOR TREATING AND PREVENTING GASTROINTESTINAL DISORDERS
|
US11318253B2
(en)
*
|
2017-08-29 |
2022-05-03 |
Clear Dart, L.L.C. |
Dart syringe projectile
|
KR101862201B1
(ko)
|
2017-08-31 |
2018-05-29 |
제이에스케이바이오메드(주) |
역류방지밸브가 구비된 마이크로젯 약물 주사 장치
|
EP3675817A1
(de)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Verfahren zur herstellung von lipidnanopartikeln
|
CN111727256A
(zh)
|
2017-09-08 |
2020-09-29 |
波赛达治疗公司 |
用于嵌合配体受体(clr)-介导的条件性基因表达的组合物和方法
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
CN111465701A
(zh)
|
2017-10-11 |
2020-07-28 |
绿光生物科技股份有限公司 |
用于三磷酸核苷和核糖核酸生成的方法和组合物
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
EP3728305A1
(de)
|
2017-12-20 |
2020-10-28 |
Poseida Therapeutics, Inc. |
Vcar-zusammensetzungen und verfahren zur verwendung
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
KR101859735B1
(ko)
*
|
2018-02-07 |
2018-05-21 |
주식회사 피테크 |
무통 주사 장치
|
EP3762015A4
(de)
|
2018-03-05 |
2022-04-27 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von morbus crohn mit anti-il23-spezifischem antikörper
|
WO2019173636A1
(en)
|
2018-03-07 |
2019-09-12 |
Poseida Therapeutics, Inc. |
Cartyrin compositions and methods for use
|
US11931551B2
(en)
*
|
2018-04-09 |
2024-03-19 |
Becton Dickinson France |
Medical injection system
|
JP2021523138A
(ja)
|
2018-05-11 |
2021-09-02 |
ヤンセン バイオテツク,インコーポレーテツド |
Il−23抗体を使用してうつを治療する方法
|
US11929160B2
(en)
|
2018-07-16 |
2024-03-12 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and compliance detection
|
JP2021530697A
(ja)
|
2018-07-18 |
2021-11-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で治療した後の持続応答予測因子
|
US20220409536A1
(en)
|
2018-09-19 |
2022-12-29 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
CA3113651A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
BR112021005467A2
(pt)
|
2018-09-24 |
2021-06-22 |
Janssen Biotech, Inc. |
método seguro e eficaz para tratar colite ulcerativa com anticorpo anti-il12/il23
|
CN113395979A
(zh)
|
2018-11-20 |
2021-09-14 |
詹森生物科技公司 |
用抗il-23特异性抗体治疗银屑病的安全且有效的方法
|
MA54562A
(fr)
|
2018-12-18 |
2021-10-27 |
Janssen Biotech Inc |
Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
|
AU2019401282A1
(en)
|
2018-12-20 |
2021-07-15 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
AU2020208828A1
(en)
|
2019-01-15 |
2021-08-05 |
Janssen Biotech, Inc. |
Anti-TNF antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
US20230072397A1
(en)
|
2019-01-16 |
2023-03-09 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
US20230159491A1
(en)
|
2019-01-16 |
2023-05-25 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
EA202192038A1
(ru)
|
2019-01-23 |
2021-10-05 |
Янссен Байотек, Инк. |
Композиции антител к фно для применения в способах лечения псориатического артрита
|
KR20210121137A
(ko)
|
2019-01-29 |
2021-10-07 |
샤이어-엔피에스 파마슈티칼즈, 인크. |
부갑상선 호르몬 변이체
|
JP2022519557A
(ja)
|
2019-01-31 |
2022-03-24 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の調製方法
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
EA202192508A1
(ru)
|
2019-03-14 |
2022-03-29 |
Янссен Байотек, Инк. |
Способы получения композиций антитела к фно
|
EP3938391A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
CA3133381A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CA3133395A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
US11780911B2
(en)
|
2019-05-23 |
2023-10-10 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
KR20220029593A
(ko)
|
2019-06-03 |
2022-03-08 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료를 위한 항-tnf 항체 조성물, 및 방법
|
JP2022535534A
(ja)
|
2019-06-03 |
2022-08-09 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
AU2020319876A1
(en)
|
2019-07-31 |
2022-02-24 |
Modernatx, Inc. |
Compositions and methods for delivery of RNA interference agents to immune cells
|
US20220265803A1
(en)
|
2019-07-31 |
2022-08-25 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
WO2021030210A1
(en)
|
2019-08-09 |
2021-02-18 |
Kaleo, Inc. |
Devices and methods for delivery of substances within a prefilled syringe
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CA3149892A1
(en)
|
2019-09-05 |
2021-03-11 |
Eric M. Ostertag |
Allogeneic cell compositions and methods of use
|
CN110882447A
(zh)
*
|
2019-11-11 |
2020-03-17 |
徐州深丰精密机械有限公司 |
一种医疗用注射器组件
|
WO2021097061A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
EP4077395A1
(de)
|
2019-12-20 |
2022-10-26 |
Poseida Therapeutics, Inc. |
Anti-muc1-zusammensetzungen und verfahren zur verwendung
|
WO2021155274A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
CA3169529A1
(en)
|
2020-03-04 |
2021-09-10 |
Jingjing Jiang |
Compositions and methods for the treatment of metabolic liver disorders
|
EP4118107A1
(de)
|
2020-03-11 |
2023-01-18 |
Poseida Therapeutics, Inc. |
Chimäre stimulationsrezeptoren und verfahren zur verwendung bei der t-zell-aktivierung und -differenzierung
|
CN115996747A
(zh)
|
2020-04-14 |
2023-04-21 |
波赛达治疗公司 |
用于治疗癌症的组合物和方法
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US11951284B2
(en)
|
2020-08-27 |
2024-04-09 |
Tandem Diabetes Care, Inc. |
Transitioning to other modes in automated insulin delivery
|
EP4231999A1
(de)
|
2020-10-21 |
2023-08-30 |
Poseida Therapeutics, Inc. |
Zusammensetzungen und verfahren zur abgabe von nukleinsäuren
|
CN116710116A
(zh)
|
2020-10-30 |
2023-09-05 |
Xeno-Interface株式会社 |
β折叠股桥肽
|
CN117083065A
(zh)
|
2020-10-30 |
2023-11-17 |
庆应义塾 |
肌肉减少症相关疾病等的新颖治疗和预防
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
KR102611990B1
(ko)
*
|
2021-02-19 |
2023-12-11 |
(주)바이오시드 |
가스압을 이용한 원터치식 반자동 무침주사기
|
US20240060090A1
(en)
|
2021-02-23 |
2024-02-22 |
Poseida Therapeutics, Inc. |
Genetically modified induced pluripotent stem cells and methods of use thereof
|
WO2022182792A1
(en)
|
2021-02-23 |
2022-09-01 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2022187671A1
(en)
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
EP4305088A1
(de)
|
2021-03-09 |
2024-01-17 |
Massachusetts Institute of Technology |
Verzweigte poly(aminoester) zur verabreichung von nukleinsäuren
|
EP4305062A1
(de)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von patienten mit psoriasisarthritis mit unzureichender reaktion auf eine tnf-therapie mit anti-il23-spezifischem antikörper
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
US20230040065A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
KR20240034215A
(ko)
|
2021-07-09 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생산하기 위한 제조 방법
|
WO2023281463A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
KR102582365B1
(ko)
*
|
2021-08-05 |
2023-09-25 |
(주)씨엔엘바이오텍 |
바늘 없는 주사기형 용기
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
US20230233667A1
(en)
|
2021-09-08 |
2023-07-27 |
Affinivax, Inc. |
Coronavirus vaccine
|
CA3234642A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
WO2023060088A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023164573A1
(en)
|
2022-02-23 |
2023-08-31 |
Poseida Therapeutics, Inc. |
Genetically modified cells and methods of use thereof
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024036273A1
(en)
|
2022-08-11 |
2024-02-15 |
Poseida Therapeutics, Inc. |
Chimeric cd8-alpha co-receptor compositions and methods of use
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|